This national agreement gives Premier members a new partner to help tackle costly challenges such as hospital-acquired pressure ulcers, wound infection, increased length of stay, and hospital readmissions.

DOYLESTOWN, Pa., April 11, 2016 – Crawford Healthcare, Inc. (“Crawford” or the “Company”) announced today the signing of a national group purchasing agreement with Premier, Inc. (“Premier”), a leading healthcare improvement company, to offer Crawford’s full line of products at specially negotiated pricing and terms. Premier unites an alliance of 3,600 hospitals and 120,000 other providers, and operates one of the largest healthcare group purchasing organizations (GPOs) in the United States.

Crawford’s innovative line of advanced wound and skin care products was designed with novel technologies to advance the standard of care in the exudate management, infection and protection segments. This national agreement gives Premier members a new partner to help tackle costly challenges such as hospital-acquired pressure ulcers, wound infection, increased length of stay, and hospital readmissions.

“We are very pleased to have been chosen for this contract based on our shared values of supporting outstanding clinical and economic outcomes,” says Terry Bromley, Senior Vice President and General Manager of Crawford’s U.S. operations. “Premier is widely recognized for having the highest ethical standards, and for its commitment to improving healthcare quality, access and affordability,” adds Bromley. “Crawford is proud to be working with such a partner.”

Among the products included in the contract with Premier are Crawford’s proven performers: KerraMax Care™, a super-absorbent dressing designed to minimize discomfort and dressing changes; KerraFoam™, a foam dressing with excellent fluid retention capabilities to prevent maceration and wound edge breakdown; KerraContact™ Ag, a contact layer containing proprietary Ag Oxysalts™ for fast and powerful antimicrobial action; and Touchless® Care, a spray-on, no-rub-in series of multipurpose treatments that soothe and protect irritated skin.

For more information about Crawford Healthcare, Inc. or its products, please visit us.crawfordhealthcare.com.

About Crawford Healthcare, Inc.
Crawford Healthcare, Inc., is a rapidly growing international company dedicated to developing innovative treatments and effective dermatological, wound care, and diagnostic products for the care and repair of skin. The Company has worked closely with healthcare professionals for more than 15 years from the international head office of its parent company, Crawford Healthcare Holdings Limited (the “Crawford Group”), in Knutsford, Cheshire, U.K. In early 2013, the Crawford Group expanded its operations and opened a United States office in Doylestown, Pa., that focuses on the Company’s portfolio of advanced wound care products. To help lead its U.S. business, the Crawford Group has assembled a skilled management team with long-standing industry backgrounds in the advanced wound care arena. The team offers more than 150 years of collective experience in the field and has deployed a nationwide direct sales team dedicated to wound, skin, and burn care.